BARDA, Evidation Partner to Support Early Detection of Respiratory Infections Via Wearables
Evidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Company News, Flu & Respiratory Infections |
Evidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MorePosted by Andy Lundin | Oct 12, 2023 | Infectious Diseases |
Researchers developed a new AI tool that was designed to make predictions about new viral variants before they actually emerge.
Read MorePosted by Eli Patterson | Oct 11, 2023 | Gastrointestinal Infections, Sponsored |
COVID-19 has reshaped the global landscape of gastrointestinal infections, notably surging norovirus cases. Coupled with an increasing immunity gap due to reduced vaccinations, healthcare systems are on alert. Seegene offers solutions for these unprecedented challenges.
Read MorePosted by Andy Lundin | Oct 9, 2023 | Sequencing Systems, Unknown Origin & Other Cancer Types |
The new NGS test detects gene fusions, translocations, and rearrangements across 361 genes from FFPE tumor tissue.
Read MorePosted by Andy Lundin | Oct 6, 2023 | Covid 19 |
Gene Bio Medical has unveiled its SwiftSwab Antigen Test Kit, which was created to help contain the transmission of new COVID variants.
Read More